EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term outcomes of tacrolimus conversion to sirolimus in kidney transplant recipients: an eight-year follow-up

Ibrahim Tawhari, Sook Park, Fatmah Yamani, Bing Ho, Mohammed Javeed Ansari, Mohammed Tawhari, Joseph Leventhal, Lorenzo Gallon

Frontiers in Nephrology · 25.05.2026 · 6

DOI: 10.3389/fneph.2026.1813146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nephrology, online erschienen am 25.05.2026. Verfasst von Ibrahim Tawhari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Nephrology, King Khalid University College of Medicine, Abha, Saudi Arabia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Calcineurin inhibitors, such as tacrolimus, are associated with long-term nephrotoxicity and renal allograft dysfunction despite evidence of improved kidney transplantation outcomes. Consequently, minimizing calcineurin inhibitor exposure has attracted considerable interest. This study aimed to investigate the long-term outcomes of late conversion of tacrolimus to sirolimus in a steroid-free immunosuppressive regimen in kidney transplant recipients.

Methods

We conducted an 8-year retrospective analysis of outcomes in 207 kidney transplant recipients enrolled in a previous randomized clinical trial, in which patients receiving maintenance therapy with tacrolimus and mycophenolate were randomized 2:1 at 6–12 months post-transplantation to conversion from tacrolimus to sirolimus or continuation of tacrolimus.

Results

Over the 8-year post-transplant follow-up, the sirolimus cohort exhibited a superior and more preserved GFR compared to the tacrolimus cohort, with a total GFR change of −1.18 mL/min/1.73 m² (95% CI, −4.86 to 3.06) with sirolimus versus −9.57 mL/min/1.73 m² (95% CI, −16.92 to −7.26) with tacrolimus, with a between-group difference of −8.39 mL/min/1.73 m². The two groups did not significantly differ in terms of graft loss, patient survival, or de novo donor-specific antibody development. The sirolimus group showed a numerically but insignificantly elevated biopsy-proven acute rejection rate. Adverse effect profiles revealed that the sirolimus group was associated with significantly lower BK viremia and cancer rates, whereas other adverse events did not significantly differ between the groups.

Conclusions

Delayed conversion from tacrolimus to sirolimus (≥6 months post-transplantation) was associated with long-term preserved estimated glomerular filtration rate without a significantly increased risk of renal allograft rejection or graft loss.

Schlagwörter

Stichwörter der Autor:innen

calcineurin inhibitorsconversionkidney transplantationlong-termoutcomessirolimus

Autor:innen und Institutionen

  • Department of Internal Medicine, Nephrology, King Khalid University College of Medicine, Abha, Saudi Arabia.
  • Department of Medicine, Division of Nephrology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
  • Department of Nephrology, King Faisal Specialist Hospital & Research Centre - Jeddah, Jeddah, Saudi Arabia.
  • College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Department of Medicine, Division of Nephrology, King Abdulaziz Medical City in Riyadh, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
  • King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Zitieren

APA

Tawhari, I., Park, S., Yamani, F., Ho, B., Ansari, M. J., Tawhari, M., Leventhal, J., & Gallon, L. (2026). Long-term outcomes of tacrolimus conversion to sirolimus in kidney transplant recipients: an eight-year follow-up. Frontiers in Nephrology, 6. https://doi.org/10.3389/fneph.2026.1813146

Vancouver

Tawhari I, Park S, Yamani F, Ho B, Ansari MJ, Tawhari M, et al. Long-term outcomes of tacrolimus conversion to sirolimus in kidney transplant recipients: an eight-year follow-up. Frontiers in Nephrology. 2026;6. doi:10.3389/fneph.2026.1813146

BibTeX
@article{Tawhari2026,
  author = {Tawhari, Ibrahim and Park, Sook and Yamani, Fatmah and Ho, Bing and Ansari, Mohammed Javeed and Tawhari, Mohammed and Leventhal, Joseph and Gallon, Lorenzo},
  title = {Long-term outcomes of tacrolimus conversion to sirolimus in kidney transplant recipients: an eight-year follow-up},
  journal = {Frontiers in Nephrology},
  year = {2026},
  volume = {6},
  doi = {10.3389/fneph.2026.1813146}
}
Kostenlos starten →